IL137178A0 - Il-18 receptors - Google Patents

Il-18 receptors

Info

Publication number
IL137178A0
IL137178A0 IL13717899A IL13717899A IL137178A0 IL 137178 A0 IL137178 A0 IL 137178A0 IL 13717899 A IL13717899 A IL 13717899A IL 13717899 A IL13717899 A IL 13717899A IL 137178 A0 IL137178 A0 IL 137178A0
Authority
IL
Israel
Prior art keywords
receptor
polypeptide
receptors
multimeric
fragment
Prior art date
Application number
IL13717899A
Other languages
English (en)
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of IL137178A0 publication Critical patent/IL137178A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
IL13717899A 1998-01-23 1999-01-22 Il-18 receptors IL137178A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7230198P 1998-01-23 1998-01-23
US7883598P 1998-03-20 1998-03-20
US9446998P 1998-07-28 1998-07-28
PCT/US1999/001419 WO1999037772A1 (en) 1998-01-23 1999-01-22 Il-18 receptors

Publications (1)

Publication Number Publication Date
IL137178A0 true IL137178A0 (en) 2001-07-24

Family

ID=27372056

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13717899A IL137178A0 (en) 1998-01-23 1999-01-22 Il-18 receptors
IL137178A IL137178A (en) 1998-01-23 2000-07-05 Il-18 receptors

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL137178A IL137178A (en) 1998-01-23 2000-07-05 Il-18 receptors

Country Status (13)

Country Link
US (4) US6589764B1 (ja)
EP (1) EP1047781B1 (ja)
JP (1) JP4271850B2 (ja)
AT (1) ATE272114T1 (ja)
AU (1) AU737592B2 (ja)
CA (1) CA2318482C (ja)
DE (1) DE69918946T2 (ja)
DK (1) DK1047781T3 (ja)
ES (1) ES2226335T3 (ja)
IL (2) IL137178A0 (ja)
NZ (1) NZ505880A (ja)
PT (1) PT1047781E (ja)
WO (1) WO1999037772A1 (ja)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
US7083949B2 (en) 1998-09-25 2006-08-01 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US6927044B2 (en) 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US20020155526A1 (en) 1998-09-30 2002-10-24 Busfield Samantha J. Novel secreted immunomodulatory proteins and uses thereof
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
ATE407950T1 (de) * 1999-12-23 2008-09-15 Zymogenetics Inc Löslicher interleukin-20 rezeptor
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
NZ520392A (en) * 2000-02-10 2005-04-29 Abbott Lab Antibodies that bind human interleukin-18 and methods of making and using
US20020025317A1 (en) * 2000-07-20 2002-02-28 Schering Ag Bispecific monoclonal antibodies to IL-12 and IL-18
US20020052475A1 (en) * 2000-07-20 2002-05-02 Schering Ag High affinity soluble interleukin-18 receptor
JP5015404B2 (ja) 2000-08-08 2012-08-29 ザイモジェネティクス， インコーポレイテッド 可溶性ｚｃｙｔｏｒ１１サイトカイン受容体
US7855269B2 (en) 2000-09-15 2010-12-21 Zymogenetics, Inc. Method for treating inflammation
US6894155B2 (en) 2000-10-11 2005-05-17 Viron Therapeutics Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
GB2375604A (en) * 2001-05-18 2002-11-20 Warner Lambert Co Methods for screening using interleukin soluble trimolecular complex
CA2451955C (en) 2001-06-26 2015-09-29 Abgenix, Inc. Antibodies to opgl
EP1293566A1 (en) 2001-09-17 2003-03-19 Societe Des Produits Nestle S.A. A soluble toll-like receptor
WO2003051384A1 (en) 2001-12-17 2003-06-26 Zymogenetics, Inc. Method for treating cervical cancer
US20040136992A1 (en) 2002-08-28 2004-07-15 Burton Paul B. J. Compositions and method for treating cardiovascular disease
EP1572291B1 (en) * 2002-10-08 2013-04-03 Ares Trading S.A. The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine
EA009026B1 (ru) 2003-03-24 2007-10-26 Займоджинетикс, Инк. Антитела против il-22ra, их партнеры по связыванию и способы их применения при воспалениях
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
ATE447587T1 (de) 2003-11-21 2009-11-15 Zymogenetics Inc Anti-il-20-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen
US7141382B1 (en) 2004-10-12 2006-11-28 Parikh Chirag R Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
MX2007004770A (es) 2004-10-22 2007-11-22 Zymogenetics Inc Anticuerpos anti-il-22ra y moleculas y metodos para usarlos en inflamacion.
AU2005327508A1 (en) * 2005-02-15 2006-08-24 Apollo Life Sciences Limited Molecules and chimeric molecules thereof
WO2007096398A1 (en) * 2006-02-22 2007-08-30 University Of Zurich Soluble receptors and methods for treating autoimmune or demyelinating diseases
US7932055B2 (en) 2006-06-22 2011-04-26 Novo Nordisk A/S Soluble heterodimeric CD94/NKG2 receptors fusion proteins
NZ581395A (en) * 2007-05-14 2012-08-31 Biogen Idec Inc Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
EP3708190A1 (en) 2010-02-26 2020-09-16 Novo Nordisk A/S Stable antibody containing compositions
US20130136733A1 (en) 2010-05-28 2013-05-30 Novo Nordisk A/S Stable Multi-Dose Compositions Comprising an Antibody and a Preservative
EP2591006B1 (en) 2010-07-09 2019-04-24 Bioverativ Therapeutics Inc. Processable single chain molecules and polypeptides made using same
TW201215405A (en) 2010-08-25 2012-04-16 Hoffmann La Roche Antibodies against IL-18R1 and uses thereof
JOP20200308A1 (ar) 2012-09-07 2017-06-16 Novartis Ag جزيئات إرتباط il-18

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
EP0533006A1 (en) * 1991-09-18 1993-03-24 F.Hoffmann-La Roche & Co. Aktiengesellschaft Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
US5470952A (en) 1993-10-20 1995-11-28 Regeneron Pharmaceuticals, Inc. CNTF and IL-6 antagonists
WO1996013593A2 (en) * 1994-10-26 1996-05-09 Procept, Inc. Soluble single chain t cell receptors
US5853721A (en) 1995-01-31 1998-12-29 Hoffmann-La Roche Inc. Antibody to interleukin-12 receptor
ATE400586T1 (de) * 1995-08-01 2008-07-15 Hoffmann La Roche Rezeptoren für das humane interleukin-12
US5776731A (en) 1996-02-21 1998-07-07 Immunex Corporation DNA encoding type-I interleukin-I receptor-like protein designated 2F1
US7141393B2 (en) 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
US6087116A (en) 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
US6280955B1 (en) * 1997-12-16 2001-08-28 Tularik Inc. Interleukin-1 receptor accessory proteins, nucleic acids and methods
US6472179B2 (en) 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US20020052475A1 (en) 2000-07-20 2002-05-02 Schering Ag High affinity soluble interleukin-18 receptor

Also Published As

Publication number Publication date
DE69918946D1 (de) 2004-09-02
US20070135625A1 (en) 2007-06-14
US7704945B2 (en) 2010-04-27
US8053233B2 (en) 2011-11-08
CA2318482A1 (en) 1999-07-29
ES2226335T3 (es) 2005-03-16
DE69918946T2 (de) 2005-07-28
AU2466899A (en) 1999-08-09
EP1047781B1 (en) 2004-07-28
WO1999037772A1 (en) 1999-07-29
ATE272114T1 (de) 2004-08-15
US7169581B2 (en) 2007-01-30
JP4271850B2 (ja) 2009-06-03
EP1047781A1 (en) 2000-11-02
US20030199040A1 (en) 2003-10-23
US6589764B1 (en) 2003-07-08
PT1047781E (pt) 2004-11-30
US20100190211A1 (en) 2010-07-29
CA2318482C (en) 2010-04-13
IL137178A (en) 2007-06-17
AU737592B2 (en) 2001-08-23
DK1047781T3 (da) 2004-12-06
JP2002500886A (ja) 2002-01-15
NZ505880A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
IL137178A0 (en) Il-18 receptors
ATE346869T1 (de) Agonistische antikörper gegen tie2
HK1028417A1 (en) Cysteine rich receptors-train
WO2003004529A3 (en) Ephrin-tie receptor materials and methods
GB0216286D0 (en) Network
ATE314371T1 (de) Spiro-indole als y5-rezeptor antagonisten
EP1580271A3 (en) Human Orphan G Protein-Coupled Receptors
ZA975671B (en) IL-8 receptor antagonists.
DE69532541D1 (de) Hochfester hochverschleissfester gesinteter Diamantkörper
DE69942981D1 (de) Flt4 (vegfr-3) als ziel für tumornachweis (imaging) und antitumortherapie
DE69709561T2 (de) Östrogen-Rezeptor
ZA969775B (en) Endothelin receptor antagonists.
ZA977301B (en) IL-8 receptor antagonists.
EP0684823A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS.
AU2001295412A1 (en) A novel polypeptide, a human cytokine receptor 10.67 and the polynucleotide encoding the polypeptide
AU1178100A (en) Novel g protein-coupled receptor protein, its dna and ligand thereof
ATE204172T1 (de) Endothelin-rezeptorantagonisten zur bekämpfung von hyperlipidämie
BR0010843A (pt) Antagonistas de receptores de il-8
AU7485996A (en) Neuropeptide y-y5 receptor
ATE429496T1 (de) Gpr54 'knock-out' säugetiere und screening- verfahren, die sie verwenden
BR0010863A (pt) Antagonistas de receptores de il-8
ZA966552B (en) Endothelin receptor antagonists.
AR002996A1 (es) Isoxazolinas mejoradas antagonistas del receptore de fibrinogeno.
ES2175842T3 (es) Antagonistas de kv2.1.
AU4169499A (en) Novel g protein-coupled receptor protein, dna and use thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed